Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

(WASHINGTON) — The U.S. Food and Drug Administration approved a first-of-its-kind insulin device today designed to automatically deliver insulin for type 1 diabetics. The device has many in the ...

The insulin delivery device market is primarily propelled by the growing incidence of diabetes, a shift toward home-based diabetes care, heightened awareness and patient education, advancements in ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin.

Today, most people who take insulin to manage diabetes inject the insulin with a needle and syringe that delivers insulin just under the skin. Several other devices for taking insulin are available, ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...

WASHINGTON -- The U.S. government has cleared the way for the first medical device that enables automated insulin dosing for people with type 2 diabetes. The plastic pod, called the Omnipod 5 ...

Types of insulin include short-acting, rapid-acting, intermediate-acting, long-acting, ultra-long-acting, and inhaled. Here's which is best for you.

Thousands of diabetic patients are hacking into their insulin pumps to make them automatically estimate blood glucose levels and adjust insulin levels accordingly, Irl Hirsch, MD, a professor at ...

A Global Business Intelligence Research report estimates the global insulin delivery devices market to be valued at $13.8 billion by 2019, growing at a compound annual growth rate of 7 percent. The ...